Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218
- PMID: 32839459
- PMCID: PMC7445165
- DOI: 10.1038/s41398-020-00966-4
Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218
Abstract
Recent genome-wide studies have begun to identify gene variants, expression profiles, and regulators associated with neuroticism, anxiety disorders, and depression. We conducted a set of experimental cell culture studies of gene regulation by micro RNAs (miRNAs), based on genome-wide transcriptome, proteome, and miRNA expression data from twenty postmortem samples of lateral amygdala from donors with known neuroticism scores. Using Ingenuity Pathway Analysis and TargetScan, we identified a list of mRNA-protein-miRNA sets whose expression patterns were consistent with miRNA-based translational repression, as a function of trait anxiety. Here, we focused on one gene from that list, which is of particular translational significance in Psychiatry: synaptic vesicle glycoprotein 2A (SV2A) is the binding site of the anticonvulsant drug levetiracetam ((S)-α-Ethyl-2-oxo-1-pyrrolidineacetamide), which has shown promise in anxiety disorder treatments. We confirmed that SV2A is associated with neuroticism or anxiety using an original GWAS of a community cohort (N = 1,706), and cross-referencing a published GWAS of multiple cohorts (Ns ranging from 340,569 to 390,278). Postmortem amygdala expression profiling implicated three putative regulatory miRNAs to target SV2A: miR-133a, miR-138, and miR-218. Moving from association to experimental causal testing in cell culture, we used a luciferase assay to demonstrate that miR-133a and miR-218, but not miR-138, significantly decreased relative luciferase activity from the SV2A dual-luciferase construct. In human neuroblastoma cells, transfection with miR-133a and miR-218 reduced both endogenous SV2A mRNA and protein levels, confirming miRNA targeting of the SV2A gene. This study illustrates the utility of combining postmortem gene expression data with GWAS to guide experimental cell culture assays examining gene regulatory mechanisms that may contribute to complex human traits. Identifying specific molecular mechanisms of gene regulation may be useful for future clinical applications in anxiety disorders or other forms of psychopathology.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Binding characteristics of levetiracetam to synaptic vesicle protein 2A (SV2A) in human brain and in CHO cells expressing the human recombinant protein.Eur J Pharmacol. 2006 Apr 24;536(1-2):102-8. doi: 10.1016/j.ejphar.2006.02.022. Epub 2006 Mar 10. Eur J Pharmacol. 2006. PMID: 16556440
-
Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats.J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):716-722. doi: 10.1007/s11596-015-1496-0. Epub 2015 Oct 22. J Huazhong Univ Sci Technolog Med Sci. 2015. PMID: 26489628
-
MicroRNA regulation of homeostatic synaptic plasticity.Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11650-5. doi: 10.1073/pnas.1017576108. Epub 2011 Jun 22. Proc Natl Acad Sci U S A. 2011. PMID: 21697510 Free PMC article.
-
Therapeutic Role of Synaptic Vesicle Glycoprotein 2A (SV2A) in Modulating Epileptogenesis.CNS Neurol Disord Drug Targets. 2017;16(4):463-471. doi: 10.2174/1871527316666170404115027. CNS Neurol Disord Drug Targets. 2017. PMID: 28393712 Review.
-
Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond.CNS Drugs. 2016 Nov;30(11):1055-1077. doi: 10.1007/s40263-016-0384-x. CNS Drugs. 2016. PMID: 27752944 Free PMC article. Review.
Cited by
-
miR-218-2 regulates cognitive functions in the hippocampus through complement component 3-dependent modulation of synaptic vesicle release.Proc Natl Acad Sci U S A. 2021 Apr 6;118(14):e2021770118. doi: 10.1073/pnas.2021770118. Proc Natl Acad Sci U S A. 2021. PMID: 33782126 Free PMC article.
-
miR-218 Promotes Dopaminergic Differentiation and Controls Neuron Excitability and Neurotransmitter Release through the Regulation of a Synaptic-Related Genes Network.J Neurosci. 2023 Nov 29;43(48):8104-8125. doi: 10.1523/JNEUROSCI.0431-23.2023. J Neurosci. 2023. PMID: 37816598 Free PMC article.
-
MAPK Is a Mutual Pathway Targeted by Anxiety-Related miRNAs, and E2F5 Is a Putative Target for Anxiolytic miRNAs.Biomolecules. 2023 Mar 16;13(3):544. doi: 10.3390/biom13030544. Biomolecules. 2023. PMID: 36979479 Free PMC article.
-
Complement Dependent Synaptic Reorganisation During Critical Periods of Brain Development and Risk for Psychiatric Disorder.Front Neurosci. 2022 May 6;16:840266. doi: 10.3389/fnins.2022.840266. eCollection 2022. Front Neurosci. 2022. PMID: 35600620 Free PMC article. Review.
-
MicroRNA regulation of prefrontal cortex development and psychiatric risk in adolescence.Semin Cell Dev Biol. 2021 Oct;118:83-91. doi: 10.1016/j.semcdb.2021.04.011. Epub 2021 Apr 28. Semin Cell Dev Biol. 2021. PMID: 33933350 Free PMC article. Review.
References
-
- John, O. P. & Srivastava, S. The big five trait taxonomy: history, measurement, and theoretical perspectives. in (eds Pervin, L. A., John, O. P.). Handbook of Personality: Theory and Research, 2nd edn, 102–138 (The Guilford Press, New York, NY, 1999).
-
- McCrae, R. R. & Costa P. T. Jr. Personality in Adulthood: A Five-Factor Theory Perspective, 2nd edn (Guilford Press, New York, NY, 2012).
-
- Vukasovic T, Bratko D. Heritability of personality: a meta-analysis of behavior genetic studies. Psychological Bull. 2015;141:769–785. - PubMed
-
- Hettema JM, Prescott CA, Kendler KS. Genetic and environmental sources of covariation between generalized anxiety disorder and neuroticism. Am. J. psychiatry. 2004;161:1581–1587. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30AG10161/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)/International
- RF1 AG036042/AG/NIA NIH HHS/United States
- R01AG36042/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)/International
- R01AG15819/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)/International
- R01 AG017917/AG/NIA NIH HHS/United States
- S10 RR023680/RR/NCRR NIH HHS/United States
- BCS-0843346/National Science Foundation (NSF)/International
- R01AG034578/U.S. Department of Health & Human Services | National Institutes of Health (NIH)/International
- R01 AG034578/AG/NIA NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
- R01AG17917/U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging)/International
- R01 AG036042/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous